Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive Leukemia-Reference-Cited by-同舟云学术

Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive Leukemia

Published:2017-12 Issue:12 Volume:17 Page:897-901
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Assi Rita,Kantarjian Hagop,Short Nicholas J.^ORCID,Daver Naval,Takahashi Koichi^ORCID,Garcia-Manero Guillermo,DiNardo Courtney^ORCID,Burger Jan,Cortes Jorge,Jain Nitin,Wierda William,Chamoun Salim^ORCID,Konopleva Marina,Jabbour Elias

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference21 articles.

1. Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies;Gökbuget;Blood,2012

2. Treatment of High-Risk Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia in Adolescents and Adults According to Early Cytologic Response and Minimal Residual Disease After Consolidation Assessed by Flow Cytometry: Final Results of the PETHEMA ALL-AR-03 Trial

3. Impact of complete molecular response on survival in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia;Short;Blood,2016

4. Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate;Thomas;Blood,2004

5. Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia;Ravandi;Cancer,2015

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia can be Treated with Chemotherapy-Free Regimens without Transplant;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. MRD in Philadelphia Chromosome-Positive ALL: Methodologies and Clinical Implications;Current Hematologic Malignancy Reports;2024-06-18

3. Advances in the treatment of adults with newly diagnosed B-cell acute lymphoblastic leukemia: the role of frontline immunotherapy-based regimens;Leukemia & Lymphoma;2024-06-08

4. SOHO State of the Art Updates and Next Questions | Next Questions: Acute Lymphoblastic Leukemia;Clinical Lymphoma Myeloma and Leukemia;2024-06

5. Asciminib Maintains Antibody-Dependent Cellular Cytotoxicity against Leukemic Blasts;Cancers;2024-03-26